# Veradermics funding rounds and investors

As of 14 Oct 2026, Veradermics has raised $150M across 1 verified round on record; latest: $150 million Series C led by SR One, announced 16 Oct 2025.

Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company.

Website: https://veradermics.com  
Headquarters: New Haven, Conn.  
Page: https://fireround.dev/companies/veradermics.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-10-16 | Series C | $150 million | SR One | abrdn, Columbia Threadneedle Investments, Infinitium, Invus, LifeSci Venture Partners, Longitude Capital, Marshall Wace, Surveyor Capital (a Citadel company), Suvretta Capital Management, Viking Global Investors | [businesswire.com](https://www.businesswire.com/news/home/20251016863981/en/Veradermics-Announces-Oversubscribed-%24150-Million-Series-C-Financing-to-Advance-VDPHL01-Through-Multiple-Phase-3-Trials-as-Potentially-the-First-Non-Hormonal-Oral-Therapeutic-for-Hair-Regrowth-in-Women-and-Men) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.